MT-ND5 Gene Mitochondrial Complex I Deficiency Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ND5 Gene Mitochondrial Complex I Deficiency.
Test Details
MT-ND5 gene mitochondrial complex I deficiency is a condition characterized by a mutation in the MT-ND5 gene, which is one of the genes that encodes a subunit of the mitochondrial complex I enzyme. Mitochondrial complex I is responsible for the first step in the electron transport chain, which is a crucial process for generating energy in the form of ATP.
A deficiency in mitochondrial complex I can lead to a variety of symptoms, including muscle weakness, developmental delay, intellectual disability, seizures, and lactic acidosis. The severity and specific symptoms can vary widely among affected individuals.
NGS (Next-Generation Sequencing) genetic testing is a method used to identify mutations in the DNA sequence of specific genes. In the case of MT-ND5 gene mitochondrial complex I deficiency, NGS genetic testing can be used to detect mutations or variants in the MT-ND5 gene that may be responsible for the condition.
This type of testing can help confirm a diagnosis, provide information about the specific mutation causing the deficiency, and guide treatment options and management strategies.
It is important to note that NGS genetic testing may not be available or necessary for all individuals suspected of having mitochondrial complex I deficiency. The decision to undergo genetic testing should be made in consultation with a healthcare professional or genetic counselor who can assess the individual’s symptoms, medical history, and family history, and provide guidance on the most appropriate diagnostic approach.
| Test Name | MT-ND5 Gene Mitochondrial complex I deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MT-ND5 Gene Mitochondrial complex I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ND5 Gene Mitochondrial complex I deficiency |
| Test Details |
MT-ND5 gene mitochondrial complex I deficiency is a condition characterized by a mutation in the MT-ND5 gene, which is one of the genes that encodes a subunit of the mitochondrial complex I enzyme. Mitochondrial complex I is responsible for the first step in the electron transport chain, which is a crucial process for generating energy in the form of ATP. A deficiency in mitochondrial complex I can lead to a variety of symptoms, including muscle weakness, developmental delay, intellectual disability, seizures, and lactic acidosis. The severity and specific symptoms can vary widely among affected individuals. NGS (Next-Generation Sequencing) genetic testing is a method used to identify mutations in the DNA sequence of specific genes. In the case of MT-ND5 gene mitochondrial complex I deficiency, NGS genetic testing can be used to detect mutations or variants in the MT-ND5 gene that may be responsible for the condition. This type of testing can help confirm a diagnosis, provide information about the specific mutation causing the deficiency, and guide treatment options and management strategies. It is important to note that NGS genetic testing may not be available or necessary for all individuals suspected of having mitochondrial complex I deficiency. The decision to undergo genetic testing should be made in consultation with a healthcare professional or genetic counselor who can assess the individual’s symptoms, medical history, and family history, and provide guidance on the most appropriate diagnostic approach. |
